Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neurotoxicity Syndromes × Doxorubicin × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 39 Breast Neoplasms 27 Lymphoma 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Sarcoma 21 Hodgkin Disease 20 Burkitt Lymphoma 20 Triple Negative Breast Neoplasms 18 Lymphoma, Follicular 14 Lymphoma, B-Cell 13 Ovarian Neoplasms 11 Neoplasms 10 Lymphoma, Non-Hodgkin 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, T-Cell, Peripheral 8 Lymphoma, Mantle-Cell 8 Endometrial Neoplasms 8 Neoplasm Metastasis 6 Multiple Myeloma 6 Lymphoma, B-Cell, Marginal Zone 6 Liposarcoma 6 Leukemia 6 Recurrence 5 Osteosarcoma 5 Neuroblastoma 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Leiomyosarcoma 5 Fallopian Tube Neoplasms 5 Urinary Bladder Neoplasms 4 Sarcoma, Ewing 4

Interventions

neurotropin 1 haloperidol decanoate 1 fludarabine phosphate 1 fludarabine 1 axicabtagene ciloleucel 1 Temozolomide 1 Tadalafil 1 Surveys and Questionnaires 1 Simvastatin 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Nutritional Status 1 N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1 Lorazepam 1 Interleukin 1 Receptor Antagonist Protein 1 Exercise Therapy 1 Exercise 1 Dexamethasone 1 Cyclophosphamide 1 Bendamustine Hydrochloride 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡